The ADAPT study validates plasma p-tau217 assays against CSF standards, outlining optimal dual cut-points for clinical ...
The coronavirus disease 2019 (COVID-19) pandemic has highlighted the need for rapid and resource-efficient molecular diagnostics that facilitate effective patient management and contain the spread of ...
The clonogenic assay measures the capacity of single cells to form colonies in vitro. It is widely used to identify and quantify self-renewing mammalian cells derived from in vitro cultures as well as ...
In a joint effort with RIKEN BioResource Research Center and Mitsubishi Tanabe Pharma Corporation, a team of researchers led by Dr. Haruhisa Inoue (Professor, Department of Cell Growth and ...
Real-World Plasma Thymidine Kinase Activity in High-Risk and Metastatic Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Breast Cancer Treated With Cyclin-Dependent Kinase ...
Immunoassays have been widely adopted for analysis and quantification of low concentration proteins. The immunoassay is selective and sensitive; however, its utility has been limited in ...
insights from industryDr. Lindsay ParkesSenior Research ScientistPorvair Sciences An Interview with Dr. Lindsay Parkes, Senior Research Scientist, Porvair Sciences In the past decade there have been ...
A high-throughput cytometry workflow consolidates marker expression, proliferation, and cytokine release into a single assay ...
Clinical trial sponsors expanding studies across Europe often face complex regulatory pathways for sample testing, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results